Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HCV, HCC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableStudy completedNCT07687758
What this trial is testing

Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP Score

Who this might be right for
Hepatitis C Virus InfectionCompensated Advanced Chronic Liver DiseaseHepatocellular Carcinoma (HCC)
Siriraj Hospital 571
Post-approval studies (Phase 4)Study completedNCT04653818
What this trial is testing

HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial

Who this might be right for
Hepatocellular CarcinomaHepatitis CNeoplasm Recurrence+1 more
Alexandria University 84
Not applicableStudy completedNCT03602703
What this trial is testing

Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs

Who this might be right for
Drug-Induced Liver Injury
Assiut University 42
Not applicableStudy completedNCT05498779
What this trial is testing

Ablation of Hepatocellular Carcinoma: a Nationwide Study

Who this might be right for
Hepatocellular CarcinomaAblationHepatitis C
Rigshospitalet, Denmark 490
Post-approval studies (Phase 4)UnknownNCT00834860
What this trial is testing

Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma

Who this might be right for
Chronic Hepatitis CHepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital 179
Not applicableStudy completedNCT03702998
What this trial is testing

Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population

Who this might be right for
HIV InfectionsHepatitis BHepatitis C+1 more
Chinese University of Hong Kong 3,900
Not applicableStudy completedNCT02785835
What this trial is testing

Hepatocellular Carcinoma in HIV-infected Patients

Who this might be right for
Hepatocellular CarcinomaHIVChronic Hepatitis C+2 more
Hospital Universitario de Valme 477
Post-approval studies (Phase 4)Ended earlyNCT05717400
What this trial is testing

Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy

Who this might be right for
Liver Cancer
M.D. Anderson Cancer Center 2
Not applicableEnded earlyNCT03534141
What this trial is testing

Mild Hypothermia and Acute Kidney Injury in Liver Transplantation

Who this might be right for
CirrhosisEnd Stage Liver DiseaseAcute Kidney Injury+7 more
University of California, San Francisco 175
Not applicableUnknownNCT04460157
What this trial is testing

Prediction of Liver-related Outcomes After HCV Cure

Who this might be right for
Hepatitis C, ChronicSustained Virological ResponseDirect-acting Antivirals+2 more
Hospital Universitario de Valme 1,035
Not applicableActive Not RecruitingNCT06842563
What this trial is testing

Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial

Who this might be right for
Hepatocellular Carcinoma (HCC)
Singlera Genomics Inc. 900
Not applicableStudy completedNCT03707080
What this trial is testing

Direct Acting Antiviral-Post Authorization Safety Study

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Target PharmaSolutions, Inc. 42
Large-scale testing (Phase 3)Study completedNCT01804829
What this trial is testing

Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.

Who this might be right for
Hepatitis C InfectionVirusesHepatocellular Carcinoma+2 more
Biotest Pharmaceuticals Corporation 80
Not applicableUnknownNCT00154531
What this trial is testing

Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI

Who this might be right for
Hepatocellular CarcinomaHepatitis BHepatitis C
National Taiwan University Hospital 230